In case you missed it, here are the biggest headlines of the week!

 

Repurposing Schizophrenia Drug for Weight Loss

schizophrenia

An article published in the Nature Communications in October 2016 tried to investigate whether the glycine transporter 1 inhibitor, commonly used as a schizophrenia medication, has any impact on metabolic homeostasis of healthy, obese and diabetic rats … [read more]

 

 

Consumption of Fatty Acids Linked to Type 2 Diabetes

type 2 diabetes

A new study suggests that diets high in polyunsaturated omega fats may increase the risk of developing type 2 diabetes … [read more]

 

 

 

 

Gut Microorganisms’ Contribution to Parkinson’s Disease

microorganisms

Most of the intestinal microorganisms influence neuronal development, behaviour, and contribute to various neurological disorders. A new finding by scientists in the United States revealed that pathological changes in the microbes of intestine represent a risk for the onset of pathogenesis of Parkinson’s disease (PD) … [read more]

 

 

Turning White Fat Brown May Help Treat Obesity and Diabetes

obesity and diabetes

Dr. Arany and his team at the Pennsylvania School of Medicine discovered a cellular signaling pathway that may be utilized for the treatment of obesity and diabetes. Their findings were published online ahead of print in Genes and Development[read more]

 

 

Effects of Diet-Induced Obesity on the Treatment of Melanoma

diet-induced obesity

A recently published study assesses the effect of diet-induced obesity on the progression of melanoma, a skin tumour with the potential of leading to skin cancer, and on the efficacy of dacarbazine in treating such tumours … [read more]

Facebook Comments